http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2251551-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8103b9197c0cd0721e4428d407aecc65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_782d4431196c6db927373313107966a1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-073 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-18 |
| filingDate | 1996-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511fc77b67c7757324c3132b44a0cab0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ea3eaad0c0dfa42c22d5b2f94eccd63 |
| publicationDate | 1997-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2251551-A1 |
| titleOfInvention | Method for treating pathological conditions of tissues with non-coherent radiation and device therefor |
| abstract | The invention relates to medicine and is designed to treat diseases accompanied by metabolic disorder, weakening of enzymatic processes, regenerative function disorder of affected tissues. The method of treating pathological tissues with a noncoherent emission implies a periodic irradiation during 1-20 minutes with IR emission having the emission power density of 50-300 mW/cm2. The irradiation is repeated in one or two days depending on the time needed to stop the pain syndrome in the process of healing of pathological tissues. The proposed method implies that the irradiation is directed at the skin site directly over the organ responsible for the course of a disease caused by metabolic, enzymatic and regeneration process disorders in tissues, said irradiation being performed by an emission in the 1-56 µm waveband in combination with linear polarization and time modulation. The method uses a package of different wavelengths within a preset range with a linear polarization and time modulation introduced depending on the nature of disease. The emission power density is also selected depending on the nature of the disease. When an electric control signal is fed from additional power supplies of the control system (2), the suggested device provides such parameters of the emission that permit to obtain the maximum curing effect. The emission source is pre-calibrated to provide a required emission power density. A broad band semiconductor silicon light emitting diode (LED) based on a supershallow "p-n" transition with the waveband of noncoherent IR emission ranging from 1 to 56 µm as the emitter. The power supply (1) is connected along the plane (a) of "p+n" or "n+p" transition to provide electric current inside the doped "p+n" or "n+p" region. The control system (2) is equipped with leads (c, d, e) for additional sources of electric field that are connected to the LED in such a way that the electric field is applied along the plane (a) of "p+n" transition providing a reverse and direct shift at the "p+n" transition. The control system (2) controls the spectrum range of the emitted light wavelengths, the degree of linear polarization and the frequency of time modulation. The control system (2) controls the LED by the electric field fed from the additional power supplies through leads (c, d, e). The value of the electric field is selected depending on the nature of the disease. |
| priorityDate | 1996-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559541 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5461123 |
Total number of triples: 22.